000			02017 a2200529 4500
005			20250513041849.0
264		0	_c19950602
008			199506s 0 0 eng d
022			_a0007-1048
024	7		_a10.1111/j.1365-2141.1995.tb08362.x _2doi
040			_aNLM _beng _cNLM
100	1		_aShepherd, P
245	0	0	_aAnalysis of molecular breakpoint and m-RNA transcripts in a prospective randomized trial of interferon in chronic myeloid leukaemia: no correlation with clinical features, cytogenetic response, duration of chronic phase, or survival. _h[electronic resource]
260			_bBritish journal of haematology _cMar 1995
300			_a546-54 p. _bdigital
500			_aPublication Type: Clinical Trial; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
650	0	4	_aAdolescent
650	0	4	_aAdult
650	0	4	_aAged
650	0	4	_aBase Sequence
650	0	4	_aFemale
650	0	4	_aFusion Proteins, bcr-abl _xgenetics
650	0	4	_aHumans
650	0	4	_aInterferon-alpha _xtherapeutic use
650	0	4	_aLeukemia, Myelogenous, Chronic, BCR-ABL Positive _xgenetics
650	0	4	_aLeukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative _xgenetics
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aMolecular Sequence Data
650	0	4	_aOncogene Proteins _xgenetics
650	0	4	_aPrognosis
650	0	4	_aProspective Studies
650	0	4	_aProtein-Tyrosine Kinases
650	0	4	_aProto-Oncogene Proteins
650	0	4	_aProto-Oncogene Proteins c-bcr
650	0	4	_aRNA Splicing
650	0	4	_aRNA, Messenger _xgenetics
650	0	4	_aRNA, Neoplasm _xgenetics
650	0	4	_aSurvival Rate
650	0	4	_aTime Factors
650	0	4	_aTranscription, Genetic _xgenetics
700	1		_aSuffolk, R
700	1		_aHalsey, J
700	1		_aAllan, N
773	0		_tBritish journal of haematology _gvol. 89 _gno. 3 _gp. 546-54
856	4	0	_uhttps://doi.org/10.1111/j.1365-2141.1995.tb08362.x _zAvailable from publisher's website
999			_c7733724 _d7733724